SCHEMBL7777699

SCHEMBL7777699

CN(C(=O)c1c(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccncc2)nn1C)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 1/20 0.43
JAK2 O60674 1/20 0.41
CA12 O43570 6/20 0.39
CA9 Q16790 6/20 0.39
CA1 P00915 5/20 0.39
CA2 P00918 5/20 0.39
PTGS2 P35354 4/20 0.39
PTGS1 P23219 3/20 0.39
CA14 Q9ULX7 2/20 0.39
MT-CO2 P00403 1/20 0.39
LMNA P02545 1/20 0.39
CA3 P07451 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA3 P0DMS8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7773225 1.00 KMT2A (0.47) KMT2AMEN1HPGDHTTKDM4E
SCHEMBL7780043 0.91 KMT2A (0.47) KMT2AMEN1HPGDHTTKDM4E
SCHEMBL7773174 0.91 KMT2A (0.47) KMT2AMEN1HPGDHTTKDM4E
SCHEMBL7779793 0.87 MAPK14 (0.43) CA12CA9CA1CA2PTGS2
SCHEMBL7779964 0.87 MAPK14 (0.43) CA12CA9CA1CA2PTGS2
SCHEMBL7779465 0.84 MAPK14 (0.45) KMT2ACA12CA9CA1CA2
SCHEMBL7773121 0.84 MAPK14 (0.45) KMT2ACA12CA9CA1CA2
SCHEMBL7779780 0.82 IKBKB (0.46) CA12CA9CA1CA2PTGS2
SCHEMBL7773321 0.82 IKBKB (0.46) CA12CA9CA1CA2PTGS2
SCHEMBL7773006 0.81 MEN1 (0.46) KMT2AMEN1JAK2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP claimed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP claimed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US claimed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP claimed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO claimed
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed